Tang Capital reports 2.25M Boundless Bio shares
Boundless Bio, Inc. insider filings show that entities affiliated with Tang Capital report initial beneficial ownership of the company’s common stock.
Rhea-AI Filing Summary
Boundless Bio, Inc. insider filings show that entities affiliated with Tang Capital report initial beneficial ownership of the company’s common stock. The Form 3 indicates indirect holdings of 2,247,512 shares of common stock, held by limited partnership and corporate vehicles associated with Tang Capital.
Kevin Tang is described as the sole manager or director of these entities and has a pecuniary interest in the shares they beneficially own. The filing is an initial ownership report and does not show any new purchases or sales of Boundless Bio stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The shares are beneficially owned by Tang Capital Partners, LP ("TCP"), Tang Capital Partners International, LP ("TCPI"), Tang Capital Partners III, Inc. ("TCP III") and Tang Capital Partners IV, Inc. ("TCP IV"). Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.
Key Figures
Key Terms
ten percent owner financial
beneficially owned financial
pecuniary interest financial
indirect financial
Form 3 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Boundless Bio (BOLD) Form 3 filed by Tang Capital report?
Is Kevin Tang a ten percent owner of Boundless Bio (BOLD) according to this Form 3?
Does the Boundless Bio (BOLD) Form 3 show any recent insider buying or selling?
AI-generated analysis. How Rhea-AI works. Not financial advice.